HealthEMA Panel Confirms Recommendation to Refuse Omeros’ YartemleaBy Naomi CalderOct 17, 2026, 2:40 AM UTC
HealthEU Panel Recommends Sobi’s TRYNGOLZA for Severe HypertriglyceridemiaBy Naomi CalderOct 16, 2026, 6:11 PM UTC
HealthEU Medicines Panel Recommends Rasonque for Metastatic Pancreatic CancerBy Naomi CalderOct 16, 2026, 6:10 AM UTC
BusinessMelinta Therapeutics Partner, Menarini Group, Submits Marketing Authorization Application for Delafloxacin in EuropeBy Nasdaq OMXMar 8, 2018, 12:01 PM UTC
BusinessCascadian Therapeutics Receives Pediatric Investigation Plan Waiver from the European Medicines AgencyBy Nasdaq OMXJan 2, 2018, 1:30 PM UTC
BusinessCascadian Therapeutics Announces Positive Regulatory Update for Tucatinib in EuropeBy Nasdaq OMXJul 11, 2017, 12:01 PM UTC
BusinessXOMA Announces Significant Step Toward Initiating Pediatric Phase 2 Clinical Study for XOMA 358 in Children with Congenital HyperinsulinismBy Nasdaq OMXOct 19, 2016, 1:01 PM UTC
BusinessHemispherx Biopharma Europe N.V./S.A. : Orphan Medicine Designation and European Medicines Agency Public Opinion Summary Published by EMA Regarding Alferon N Injection® as a Treatment of Middle East Respiratory Syndrome (MERS)By Nasdaq OMXJan 20, 2016, 1:30 PM UTC
